51. Diaz -Montero CM, Salem ML, Nishimura MI, Garrett -Mayer E, Cole DJ, Montero AJ. Increased circulating myeloid -derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin- cyclophosphamide chemotherapy. Cancer Immunol Immunother 2009;58:49-59. 52. Montero AJ, Diaz -Montero CM, Deutsch YE, et al. Phase 2 study of neoadjuvant treatment with NOV -002 in combination with doxorubicin and cyclophosphamide followed Protocol Version 8.0. September 19 , 2018 Page | 82 by docetaxel in patients with HER -2 negative clinical stage II -IIIc breast cancer. Breast Cancer Res Treat 2012;132:215-23. 53.